• Public Preferences for Reducing Health Inequality in Japan: A National Survey

    Jan 1, 2026, 00:00

  • Latin American and Caribbean Trends and Health Priorities in Cost-Effectiveness Studies: A Bibliometric Analysis in Scopus in the 21st Century

    Jan 1, 2026, 00:00

  • Table of Contents

    Jan 1, 2026, 00:00

  • Person-Centered Intervention for People Living With HIV in the Philippines: A Cost-Effective Approach for Resource Allocation Decisions

    Jan 1, 2026, 00:00

  • Adapting a Benefit Trade-Off Instrument to Measure Health Inequality Aversion in the United States

    Jan 1, 2026, 00:00

  • Cost-Analysis of Adherence to Antimicrobial Guidelines as Part of Antimicrobial Stewardship Strategies in 6 Latin American Countries: A Pilot Experience Focusing on Economic Impact

    Jan 1, 2026, 00:00

  • Translation and Testing Psychometric Properties of the Thai Version of Vision Bolt-On EQ-5D in Patients With Visual Impairment

    Jan 1, 2026, 00:00

  • Reducing the Travel Burden for Patients to Access Specialized Medicines in Paraná, Brazil

    Jan 1, 2026, 00:00

  • Averting Cancer: The Economic Case for Expanding HPV Vaccination

    Jan 1, 2026, 00:00

  • Evaluating the Factor Structure of the Preliminary Version of EuroQol Health and Well-Being Instrument in China: A Replication of the Confirmatory Factor Analysis

    Jan 1, 2026, 00:00

  • Editorial Board

    Jan 1, 2026, 00:00

  • From Model to Clinic: Practical Considerations for Applying the Chinese Diabetes Risk Score in Prediabetes Screening

    Jan 1, 2026, 00:00

  • Disparities in Out-of-Pocket Expenditures Among Hospitalized Patients With COVID-19 in Iran: A Decomposition Analysis of Inequality

    Jan 1, 2026, 00:00

  • Real-World Effectiveness and Cost-Utility Analysis of Second-Line Immunotherapy for Non-Oncogene-Addicted Advanced Non-Small Cell Lung Cancer

    Jan 1, 2026, 00:00

  • Cost-Effectiveness of Text Messaging to Reengage Culturally and Linguistically Diverse Communities to Breast Cancer Screening: A Modeling Study

    Jan 1, 2026, 00:00

  • A Framework for Patient Prioritization in Bariatric Surgery Using a Predictive Success Score Versus a First-In First-Out Approach: A Cost-Effectiveness Analysis

    Jan 1, 2026, 00:00

  • Prevention of Heart Failure With Icosapent Ethyl Results in Cost-Savings in the Spanish Population With Established Cardiovascular Disease

    Jan 1, 2026, 00:00

  • What Role Does Equity Play in Australia’s Health Technology Assessment Processes? A Review of the Pharmaceutical Benefits Advisory Committee Recommendations Regarding Vaccines

    Jan 1, 2026, 00:00

  • Valuation of EQ-5D Health States for Adults in Low-, Lower-Middle, and Upper-Middle-Income Countries: A Systematic Review

    Jan 1, 2026, 00:00

  • Author Reply

    Jan 1, 2026, 00:00

  • Learning From Local Contexts: Practical Pathways Toward Health Equity

    Jan 1, 2026, 00:00

  • Editorial Board

    Nov 5, 2025, 08:27

  • Cost Analysis of Diabetes Mellitus Treatment in the Public Sector in Dubai, The United Arab Emirates: Analysis Based on a Global Perspective Model

    Nov 1, 2025, 00:00

  • Impact of Severe Hemophilia on Costs and Quality of Life in South American Men: Findings From the CHESS LATAM Study

    Nov 1, 2025, 00:00

  • Cost-Utility Analysis of Expanding Human Papillomavirus Vaccination to Adult Women in Indonesia: A Markov Model Approach

    Nov 1, 2025, 00:00

  • Medicines Policy in Action: The Impact on Volume and Cost of Biologic Medicines After Biosimilar Introduction

    Nov 1, 2025, 00:00

  • Table of Contents

    Nov 1, 2025, 00:00

  • Healthcare Costs and Main Characteristics of Childbirth and Neonatal Inpatient Care From the Brazilian Public Health System Perspective

    Nov 1, 2025, 00:00

  • Self-Reported Health-Related Quality of Life in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions

    Nov 1, 2025, 00:00

  • Cost-Effectiveness Analysis Comparing Ceftazidime/Avibactam With Standard of Care in the Treatment of Hospital and Ventilator-Acquired Pneumonia in the Philippines

    Nov 1, 2025, 00:00

  • Correction

    Nov 1, 2025, 00:00

  • Epidemiology, Real-World Treatment, and Economic Burden of Waldenström Macroglobulinemia: A Comprehensive Analysis Based on Anonymized Claims Data Between 2010 and 2022

    Nov 1, 2025, 00:00

  • Psychometric Validation of EQ-5D-5L in Individuals With Chronic Spinal Cord Injury in China

    Nov 1, 2025, 00:00

  • Comparison of Cancer Registry Data Between Sweden and China and the Impact on Real-World Health Research

    Nov 1, 2025, 00:00

  • Disseminated Histoplasmosis in People Living With HIV: What Are the Care Costs for Brazil?

    Nov 1, 2025, 00:00

  • Cost and Budget Impact of Layering Depression Care Onto Existing HIV and Noncommunicable Disease Care Services in Western Kenya

    Nov 1, 2025, 00:00

  • Predicting the EQ-5D-5L Utility Scores From the Impact of Vision Impairment Questionnaire in Thai Patients

    Nov 1, 2025, 00:00

  • Valuation of the Alzheimer’s Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in Chile

    Nov 1, 2025, 00:00

  • Disclaimer

    Oct 23, 2025, 09:07

  • RWD87 ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE MEDICATIONS BASED ON REAL-WORLD DATA

    Oct 1, 2025, 00:00

  • RWD138 A PRACTICAL APPROACH TO IDENTIFYING EARLY NEONATAL CONDITIONS IN A DE-IDENTIFIED DATABASE: NATIONAL HEALTH INSURANCE RESEARCH DATABASE (NHIRD)

    Oct 1, 2025, 00:00

  • RWD216 REAL-WORLD STUDY ON TREATMENT PATTERNS AND ECONOMIC BURDEN OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN CHINA

    Oct 1, 2025, 00:00

  • RWD225 COST-EFFECTIVENESS OF DOCETAXEL VERSUS IMMUNE CHECKPOINT INHIBITORS AS TREATMENT FOR ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER: A TARGETED LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD158 PERFORMANCE OF CHATGPT-4O AND CLAUDE 3.5 SONNET IN TITLE AND ABSTRACT SCREENING FOR A SYSTEMATIC REVIEW IN OBSTETRICS

    Oct 1, 2025, 00:00

  • RWD188 ADOPTION AND CHALLENGES OF ELECTRONIC CLINICAL OUTCOME ASSESSMENTS AND PATIENT-REPORTED OUTCOMES IN CHINA: INSIGHTS FROM A SURVEY OF HEALTHCARE PROFESSIONALS AND INDUSTRY STAKEHOLDERS

    Oct 1, 2025, 00:00

  • RWD298 PUBLIC HEALTH IMPACT ASSESSMENT OF RSVPREF3 OA ADJUVANTED VACCINE ON RESPIRATORY SYNCYTIA VIRUS IN TAIWAN, HONG KONG, AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD292 PREFERENCE FOR VIRTUAL REALITY EXERGAME IN WEIGHT CONTROL SETTING AMONG YOUNG ADULTS: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD25 ASSOCIATION BETWEEN BARRIERS TO ACCESSING GENERAL PRACTITIONERS AND EMERGENCY DEPARTMENT VISITS IN NEW ZEALAND

    Oct 1, 2025, 00:00

  • RWD105 A REVIEW OF THE CHALLENGES AND OPPORTUNITIES FOR THE USE OF REAL-WORLD EVIDENCE FOR MEDICAL DEVICES IN JAPAN

    Oct 1, 2025, 00:00

  • RWD122 COST-EFFECTIVENESS ANALYSIS OF PRENATAL DIAGNOSTIC STRATEGIES AMONG KOREAN PREGNANT WOMEN

    Oct 1, 2025, 00:00

  • RWD51 CONSENSUS-BASED GUIDANCE FOR BONE HEALTH OPTIMIZATION IN SPINE SURGERY

    Oct 1, 2025, 00:00

  • RWD286 ECONOMIC EVALUATION ON DENTAL CARIES PREVENTIVE INTERVENTIONS FOR CHILDREN USING A PRIORITY-SETTING APPROACH IN AUSTRALIA

    Oct 1, 2025, 00:00

  • RWD282 REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS IN JAPAN: A RETROSPECTIVE CLAIMS ANALYSIS

    Oct 1, 2025, 00:00

  • RWD270 ENHANCING CAUSAL DISCOVERY IN CHRONIC DISEASES: THE MAGIC FRAMEWORK USING MULTIPLE LLMS

    Oct 1, 2025, 00:00

  • RWD85 PRICE VARIATIONS AMONG STANDARDIZED VOLUNTARY HEALTH INSURANCE PLANS: EVIDENCE FROM HONG KONG

    Oct 1, 2025, 00:00

  • RWD74 USE OF RWE TO INFORM SURVIVAL EXTRAPOLATION IN HEALTH ECONOMIC APPRAISALS OF CANCER DRUGS IN SWEDEN: A REVIEW OF NATIONAL HEALTH ECONOMIC REPORTS 2010-2024

    Oct 1, 2025, 00:00

  • RWD106 PREDICTION OF RARE DISEASE MEDICATION TRANSITION PATTERNS BASED ON AN INTERPRETABLE MACHINE LEARNING MODEL

    Oct 1, 2025, 00:00

  • RWD112 ECONOMIC EVALUATION OF SELUMETINIB FOR TREATING PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 INOPERABLE PLEXIFORM NEUROFIBROMAS IN THAILAND

    Oct 1, 2025, 00:00

  • RWD242 PROPOSAL OF USING CLAIMS-BASED DIAGNOSES AND PRENATAL EXAMINATIONS TO IDENTIFY PREGNANCY IN TAIWAN: NATIONAL HEALTH INSURANCE RESEARCH DATABASE

    Oct 1, 2025, 00:00

  • RWD257 HEALTH SAVINGS IMPACT OF MULTIVITAMIN SUPPLEMENTATION IN TAIWAN: A DEMENTIA RISK REDUCTION ECONOMIC MODEL

    Oct 1, 2025, 00:00

  • RWD308 DOES IMPROVED HOSPITAL MANAGEMENT ENHANCE HEALTHCARE EFFICIENCY? EVIDENCE FROM COUNTY-LEVEL HOSPITALS IN CHINA

    Oct 1, 2025, 00:00

  • RWD236 THE HEALTH-RELATED QUALITY OF LIFE, RENAL DYSFUNCTION AND BLADDER STONE ODDS AMONG INDIVIDUALS WITH SPINAL CORD INJURY WITH DIFFERENT BLADDER EMPTYING METHODS SURVEYED ACROSS CHINA: AN EXPLORATORY ANALYSES FROM TWO NATIONAL SURVEYS

    Oct 1, 2025, 00:00

  • RWD10 PREFERENCES FOR ADOPTING ARTIFICIAL INTELLIGENCE IN RADIATION THERAPY TREATMENT: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD140 REAL-WORLD UTILIZATION, PERSISTENCE, AND EFFECTIVENESS OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE ASTHMA: A MULTICENTER RETROSPECTIVE COHORT STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD41 REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF FIRST-LINE THERAPIES OF HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD103 CHARACTERISTICS AND APPLICATIONS OF BODY SIZE DATA IN JAPANESE CLAIMS DATABASES

    Oct 1, 2025, 00:00

  • RWD317 THE BURDEN OF JAPANESE ENCEPHALITIS IN THE ASIA-PACIFIC: INSIGHTS FROM REAL-WORLD DATA

    Oct 1, 2025, 00:00

  • RWD30 DETERMINANTS OF WILLINGNESS TO ACCEPT THE PNEUMOCOCCAL VACCINE: AN POPULATION-BASED STUDY IN HONG KONG

    Oct 1, 2025, 00:00

  • RWD128 INCORPORATING REAL-WORLD DATA AND MATHEMATICAL MODELING TO ESTIMATE THE UNDIAGNOSED CHRONIC HEPATITIS B POPULATION

    Oct 1, 2025, 00:00

  • RWD246 CONSUMER PREFERENCES FOR ATTRIBUTES AMONG VOLUNTARY HEALTH INSURANCE PLANS: A SYSTEMATIC REVIEW

    Oct 1, 2025, 00:00

  • RWD14 ASSESSMENT OF STROKE PATTERNS AND RISK FACTORS IN NORTHEAST INDIA: A HOSPITAL-BASED PROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD307 EXPLORING LONG COVID IN TAIWANESE CHILDREN: IMMUNOLOGICAL INSIGHTS AND CLINICAL IMPACTS

    Oct 1, 2025, 00:00

  • RWD314 UNDERSTANDING THE IMPACT OF PATIENT ACTIVATION LEVELS ON ALZHEIMER’S CAREGIVING IN CHINA

    Oct 1, 2025, 00:00

  • RWD61 CHARACTERISING THE LATENCY PERIOD OF SECONDARY PRIMARY MALIGNANCY AND LYMPHOMA ONSET FOLLOWING TISAGENLECLEUCEL (CAR-T CELL THERAPY): A REAL-WORLD DATA ANALYSIS

    Oct 1, 2025, 00:00

  • RWD124 IDENTIFYING RISK-FACTORS ASSOCIATED WITH POSTPARTUM DEPRESSION THROUGH CLAIMS DATA IN JAPAN

    Oct 1, 2025, 00:00

  • RWD297 REAL-WORLD EVIDENCE USE IN JAPANESE HTA: INSIGHTS FROM MANUFACTURER SUBMISSIONS AND PUBLIC ANALYSES (2019-2025)

    Oct 1, 2025, 00:00

  • RWD102 ASSESSING THE COST-UTILITY OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE TREATMENT AND THE NEED FOR REAL-WORLD EVIDENCE: A SINGAPORE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD254 BENEFIT OF IMMEDIATE INITIATION OF NIRMATRELVIR/RITONAVIR AGAINST LONG COVID: REAL-WORLD COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD115 COST-EFFECTIVENESS OF BUPROPION FOR SELF-CARE ADHERENCE AND GLYCAEMIC CONTROL IN MULTIMORBID TYPE 2 DIABETES MELLITUS AND MILD DEPRESSION [ADHERE-DM] – A CROSS-OVER RANDOMIZED CONTROLLED TRIAL-BASED ECONOMIC EVALUATION

    Oct 1, 2025, 00:00

  • RWD176 EVALUATING FIT-FOR-PURPOSE ANONYMIZATION STRATEGIES FOR JAPANESE REAL-WORLD DATA UNDER EU DATA PROTECTION STANDARDS

    Oct 1, 2025, 00:00

  • RWD309 USING REAL WORLD DATA TO ESTIMATE COMPLICATION COSTS FOR A DIABETES COST-EFFECTIVENESS MODEL: AN AUSTRALIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD116 DISPARITIES IN HEALTH OUTCOMES AND CARE AMONG ALK-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS: REAL-WORLD EVIDENCE OF SOCIAL DETERMINANTS OF HEALTH

    Oct 1, 2025, 00:00

  • RWD162 DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR THE RISK OF SARCOPENIA IN PATIENTS WITH COPD

    Oct 1, 2025, 00:00

  • RWD300 CLINICAL SAFETY ANALYSIS OF AMINOPHYLLINE INJECTION: A RETROSPECTIVE COHORT STUDY BASED ON ELECTRONIC HEALTH RECORDS IN CHINA

    Oct 1, 2025, 00:00

  • RWD50 CAN EQ-5D-5L DISCRIMINATE THE CLINICAL SEVERITY OF ASTHMA?

    Oct 1, 2025, 00:00

  • RWD63 METHOD OF AN EPIDEMIOLOGICAL RISK STUDY IN TENS OF THOUSANDS PATIENTS WITH WEARABLE CARDIOVERTER DEFIBRILLATOR FOR PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE PATIENTS WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION

    Oct 1, 2025, 00:00

  • RWD219 SYMPTOM NETWORKS OF DEPRESSION AND ANXIETY IN PATIENTS WITH A HISTORY OF HEMORRHOIDS: EVIDENCE FROM THE UK BIOBANK

    Oct 1, 2025, 00:00

  • RWD240 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT ATEZOLIZUMAB OR PEMBROLIZUMAB IN STAGE II-IIIA NON-SMALL CELL LUNG CANCER PATIENTS WITH PD-L1 ≥1% EXPRESSING IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD21 PHARMACEUTICAL APPROACHES TO ENHANCING RWE DATA COLLECTED IN NON-INTERVENTIONAL STUDIES

    Oct 1, 2025, 00:00

  • RWD284 THE ASSOCIATION BETWEEN ANNUAL HOUSEHOLD INCOME AND TOTAL MONTHLY AMOUNT OF OUT-OF-POCKET MEDICAL EXPENSES PATIENTS ARE WILLING TO PAY AMONG PATIENTS OF INFERTILITY IN JAPAN: A CROSS-SECTIONAL PATIENT SURVEY

    Oct 1, 2025, 00:00

  • RWD72 EVALUATING THE OPTIMAL AGE FOR NATIONAL GASTRIC CANCER SCREENING IN KOREA: A REAL-WORLD, POPULATION-BASED COHORT

    Oct 1, 2025, 00:00

  • RWD313 THE GAP BETWEEN RETAIL PHARMACY PRICES AND GOVERNMENT REFERENCE PRICES IN CHINA: A CASE STUDY OF COMMON STATIN DRUGS

    Oct 1, 2025, 00:00

  • RWD251 ASSOCIATION OF INITIAL Z-DRUG PRESCRIPTION DURATION AND LONG-TERM USE

    Oct 1, 2025, 00:00

  • RWD239 ADVANCING COLORECTAL CANCER (CRC) RESEARCH IN JAPAN: INSIGHTS FROM ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATA IN JAPAN

    Oct 1, 2025, 00:00

  • RWD40 EVALUATING THE REPRESENTATIVENESS OF A REAL-WORLD ONCOLOGY DATABASE DEVELOPED BY THE J-CONNECT CONSORTIUM: COMPARISON WITH JAPAN'S NATIONAL CANCER REGISTRY

    Oct 1, 2025, 00:00

  • RWD11 INTERVENTIONS PROMOTING THE ACCEPTANCE AND UPTAKE OF GENERIC MEDICINES: A SYSTEMATIC REVIEW

    Oct 1, 2025, 00:00

  • RWD218 OVERVIEW OF RARE DISEASE PATIENT-CENTERED STUDIES METHODOLOGIES AND RECOMMENDATIONS TO OVERCOME CHALLENGES

    Oct 1, 2025, 00:00

  • RWD247 GEOGRAPHIC DISPARITIES IN ACCESS TO NATIONALLY NEGOTIATED ANTICANCER MEDICINES IN CHINA

    Oct 1, 2025, 00:00

  • RWD248 DRUG SURVIVAL, SWITCHING PATTERN, AND COSTS OF MODERATE TO SEVERE PSORIASIS PATIENTS TREATED WITH BIOLOGICS IN CHINA

    Oct 1, 2025, 00:00

  • RWD206 SYSTEMATIC REVIEW AND QUALITY ASSESSMENT OF PHARMACOECONOMIC RESEARCH LITERATURE ON TRADITIONAL CHINESE MEDICINE

    Oct 1, 2025, 00:00

  • RWD154 PREFERENCES AND WILLINGNESS TO PAY FOR MAMMOGRAPHY SCREENING SERVICES AMONG WORKING-AGE URBAN WOMEN IN THAILAND

    Oct 1, 2025, 00:00

  • RWD255 IMPORTANT FEATURES OF TELEREHABILITATION FOR MUSCULOSKELETAL PATIENTS: APPLYING AN IMPLEMENTATION SCIENCE FRAMEWORK TO INFORM THE SELECTION OF ATTRIBUTES FOR DISCRETE CHOICE EXPERIMENTS

    Oct 1, 2025, 00:00

  • RWD302 UTILIZATION OF PATIENT-EXPERIENCED DATA IN HEALTH TECHNOLOGY ASSESSMENTS IN ASIA PACIFIC REGION

    Oct 1, 2025, 00:00

  • RWD305 IMPACT OF CAREGIVING ON THE DISEASE BURDEN AMONG PATIENTS WITH FEMALE-SPECIFIC CANCERS (BREAST, CERVICAL, OVARIAN, UTERINE) IN JAPAN

    Oct 1, 2025, 00:00

  • RWD198 ESTIMATING THRESHOLD FOR GOOD QUALITY OF LIFE IN AGED CARE RESIDENTS: ANCHOR-BASED CUT-OFF FOR THE QUALITY OF LIFE-AGED CARE CONSUMERS INSTRUMENT

    Oct 1, 2025, 00:00

  • RWD253 FORECASTING SURVIVAL IN NASOPHARYNGEAL CANCER PATIENTS WITH DIABETES THROUGH MACHINE LEARNING: A POPULATION-BASED ANALYSIS

    Oct 1, 2025, 00:00

  • RWD84 PATIENT VOICES IN HEALTH TECHNOLOGY ASSESSMENTS: INSIGHTS FROM AUSTRALIA AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD271 SEQUENTIAL CDK4/6 INHIBITOR THERAPY VERSUS MTOR INHIBITOR THERAPY FOLLOWING INITIAL CDK4/6 INHIBITOR IN HR+/HER2- ADVANCED BREAST CANCER

    Oct 1, 2025, 00:00

  • RWD143 ARTIFICIAL INTELLIGENCE ADOPTION IN CLINICAL PRACTICE IN CHINA: PATTERNS AND CHALLENGES

    Oct 1, 2025, 00:00

  • RWD91 DIRECT MEDICAL COSTS OF NASOPHARYNGEAL CARCINOMA IN INDONESIA: A HEALTHCARE PAYER PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD311 EXPLORING THE EVALUATION OF NETWORK META-ANALYSIS ASSUMPTIONS: CURRENT APPROACHES AND PRACTICES

    Oct 1, 2025, 00:00

  • RWD235 THE SOCIO-ECONOMIC BURDEN OF TERMINAL CANCER: REAL-WORLD EVIDENCE FROM BULGARIA

    Oct 1, 2025, 00:00

  • RWD48 THE IMPACT OF ENTERAL NUTRITION ON THE SHORT-TERM AND SURVIVAL OUTCOMES OF LUNG CANCER AND BREAST CANCER PATIENTS UNDERGOING MEDICAL TREATMENT

    Oct 1, 2025, 00:00

  • RWD92 STATIN USE AND THE PROGRESSION OF PARKINSON’S DISEASE: A POPULATION-BASED COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD269 A MACHINE LEARNING-DRIVEN MULTIDIMENSIONAL EVALUATION OF TANDOSPIRONE FORMULATIONS BASED ON REAL-WORLD EVIDENCE

    Oct 1, 2025, 00:00

  • RWD195 ESTIMATING THE AVERAGE TREATMENT EFFECT AMONG PATIENTS WITH HEART FAILURE USING TARGETED MAXIMUM LIKELIHOOD ESTIMATION: IMPLICATIONS FROM A LARGE-SCALE HEALTH ADMINISTRATIVE DATABASE

    Oct 1, 2025, 00:00

  • RWD244 BODY WEIGHT-ASSOCIATED DIFFERENCES IN ADVERSE DRUG REACTION PROFILES OF AROMATASE INHIBITORS: A REAL-WORLD PHARMACOVIGILANCE STUDY USING FAERS DATABASE

    Oct 1, 2025, 00:00

  • RWD66 HEALTH-RELATED QUALITY OF LIFE AND ITS DETERMINANTS AMONG INDIVIDUALS WITH SPINAL CORD INJURY IN CHINA: EXPLORATORY ANALYSES FROM TWO NATIONAL SURVEYS

    Oct 1, 2025, 00:00

  • RWD203 INEQUALITY AND DETERMINANTS OF ACCESS TO ESSENTIAL ANTICANCER MEDICINES FOR CHILDREN IN CHINA

    Oct 1, 2025, 00:00

  • RWD34 GENERATING REAL-WORLD UTILITY VALUES FOR PEDIATRIC HEALTH STATES IN TAIWAN: A NATIONWIDE EQ-5D-Y-3L VALUATION STUDY USING COMPOSITE TIME TRADE-OFF

    Oct 1, 2025, 00:00

  • RWD93 REAL-WORLD EFFECTIVENESS OF ATEZOLIZUMAB-BEVACIZUMAB, LENVATINIB AND SORAFENIB IN THE PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD37 ADOPTING A CLOSED INTEGRATED PERIPHERAL INTRAVENOUS CANNULA SYSTEM IN AN AUSTRALIAN HOSPITAL: CLINICAL AND ECONOMIC IMPACT

    Oct 1, 2025, 00:00

  • RWD45 OUT OF POCKET COSTS AND AFFORDABILITY OF AUSTRALIAN EATING DISORDER MEDICARE BENEFITS SCHEME SERVICES USING LINKED DATA

    Oct 1, 2025, 00:00

  • RWD192 IMPLEMENTATION OF OSTEOPOROSIS SCREENING IN HONG KONG: PERSPECTIVES OF HEALTHCARE PROVIDERS THROUGH THE LENS OF THE CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH

    Oct 1, 2025, 00:00

  • RWD31 ASSESSING ADOPTION AND FEASIBILITY OF THE HONG KONG REFERENCE FRAMEWORK FOR PREVENTIVE CARE IN OLDER ADULTS: A CROSS-SECTIONAL SURVEY OF PRIMARY CARE PRACTITIONERS

    Oct 1, 2025, 00:00

  • RWD20 HOW CAN WE ENHANCE THE USE OF RWE IN REIMBURSEMENT DECISIONS? BEST PRACTICES AND RECOMMENDATIONS

    Oct 1, 2025, 00:00

  • RWD54 EXPLORATORY DESCRIPTIVE ANALYSIS OF PERIOPERATIVE STOMA CARE AND OUTCOMES: COMPARING JAPAN TO GLOBAL AVERAGES

    Oct 1, 2025, 00:00

  • RWD82 LEVERAGING REAL-WORLD DATA (RWD) TO INFORM DRUG REIMBURSEMENT IN ASIA-PACIFIC: ADDRESSING CHALLENGES AND BUILDING SOLUTIONS

    Oct 1, 2025, 00:00

  • RWD226 MULTIDIMENSIONAL BURDEN OF NEUROFIBROMATOSIS TYPE 1 (NF1): A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD125 INTEGRATING REAL WORLD EVIDENCE IN ECONOMIC EVALUATION OF HERPES ZOSTER VACCINATION AMONG KIDNEY TRANSPLANT PATIENTS IN THAILAND

    Oct 1, 2025, 00:00

  • RWD249 CRYOBALLOON VERSUS RADIOFREQUENCY ABLATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2025, 00:00

  • RWD22 MINDFULNESS-BASED INTERVENTIONS FOR PSYCHOLOGICAL DISTRESS IN LUNG CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD319 AN EMPIRICAL STUDY ON THE DISCOUNTING RATE OF PHARMACOECONOMIC EVALUATIONS IN CHINA

    Oct 1, 2025, 00:00

  • RWD73 THE SOCIO-ECONOMIC BURDEN OF END-STAGE KIDNEY DISEASE: REAL-WORLD EVIDENCE FROM BULGARIA

    Oct 1, 2025, 00:00

  • RWD75 USING REAL WORLD DATA TO ESTIMATE THE COST OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) INFECTION IN A HIGH-RISK AUSTRALIAN POPULATION

    Oct 1, 2025, 00:00

  • RWD320 COST-EFFECTIVENESS OF RIBOCICLIB PLUS LETROZOLE FOR PREMENOPAUSAL WOMEN WITH HR+/HER2- ADVANCED BREAST CANCER IN THAILAND: A SOCIETAL PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD312 CHANGING ETIOLOGY OF CIRRHOSIS AND OTHER CHRONIC LIVER DISEASES: IMPLICATIONS FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE IN NON-CIRRHOTIC PATIENTS

    Oct 1, 2025, 00:00

  • RWD323 UNLOCKING PREFERENCES FOR WORK-LIFE BALANCE AND FERTILITY POLICIES AMONG WORKING WOMEN IN EAST ASIA: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD315 COST-EFFECTIVENESS OF CLINICAL BREAST EXAMINATION AS SCREENING MODALITY FOR BREAST CANCER IN VIETNAM: A MARKOV MODELLING

    Oct 1, 2025, 00:00

  • RWD104 EVALUATING FERTILITY TREATMENT COSTS IN JAPAN: A MICRO-COSTING ANALYSIS

    Oct 1, 2025, 00:00

  • RWD227 DAILY DOSES AND DURATION OF GABAPENTIN AND PREGABALIN USE FOR PAIN MANAGEMENT AMONG OPIOID USERS BELOW AND ABOVE 65 YEARS OLD: TRENDS AND PATTERNS

    Oct 1, 2025, 00:00

  • RWD153 ECONOMIC EVALUATIONS OF ORPHAN DRUGS FOR RARE KIDNEY DISEASES IN LOW AND MIDDLE INCOME COUNTRIES: A SYSTEMATIC REVIEW AND BIBLIOMETRIC ANALYSIS

    Oct 1, 2025, 00:00

  • RWD110 POLYPHARMACY AND RISK OF MAJOR CARDIOVASCULAR EVENTS AMONG CHINESE PATIENTS WITH DIABETES: A RETROSPECTIVE COHORT STUDY USING INSTRUMENTAL VARIABLE ANALYSIS

    Oct 1, 2025, 00:00

  • RWD126 UNDERSTANDING REAL-WORLD CLINICAL AND ECONOMIC BURDEN OF DIFFERENT DEVICES STRATEGIES FOR THE ENDOVASCULAR TREATMENT OF SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN JAPAN: A REAL-WORLD CLAIMS DATA ANALYSIS PROTOCOL

    Oct 1, 2025, 00:00

  • RWD78 BURDEN OF INTRAVENOUS IMMUNOGLOBULIN USE AMONG ADULTS WITH GENERALIZED MYASTHENIA GRAVIS IN JAPAN

    Oct 1, 2025, 00:00

  • RWD283 COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB AND ATEZOLIZUMAB WITH CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR FIRST-LINE TREATMENT OF EXTENSIVE-STAGE SMALL-CELL LUNG CANCER IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD256 COMPARATIVE EFFECTS OF SMOKING CESSATION INTERVENTION FOR ADOLESCENTS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD149 ECONOMIC IMPLICATIONS OF GENERIC POMALIDOMIDE ADOPTION IN THE MANAGEMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: A BUDGET IMPACT ANALYSIS AT THE JALISCO INSTITUTE OF CANCEROLOGY

    Oct 1, 2025, 00:00

  • RWD321 COST-EFFECTIVENESS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL IN ELDERLY PATIENTS WITH SEVERE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Oct 1, 2025, 00:00

  • RWD193 DEMOGRAPHIC AND LIFESTYLE DETERMINANTS OF SCREEN USE PATTERNS IN HONG KONG SECONDARY SCHOOL STUDENTS

    Oct 1, 2025, 00:00

  • RWD71 ESTIMATING TREATMENT EFFECT ON SURVIVAL OUTCOMES FROM REAL WORLD DATA: INVERSE PROBABILITY OF TREATMENT WEIGHTING WITH MISSING DATA AND NON-PROPORTIONAL HAZARDS

    Oct 1, 2025, 00:00

  • RWD23 RESEARCH ON THE DRIVING MECHANISM OF CORPORATE PARTICIPATION IN GOVERNANCE FOR HEALTH—AN EMPIRICAL ANALYSIS BASED ON CHINESE LISTED COMPANIES

    Oct 1, 2025, 00:00

  • RWD288 REHABILITATION FOR PATIENTS WITH CANCER: SURVIVAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION BASED ON MULTICENTER CANCER REGISTRY AND ADMINISTRATIVE DATA IN JAPANESE REAL-WORLD SETTINGS

    Oct 1, 2025, 00:00

  • RWD131 COST-EFFECTIVENESS OF DOSTARLIMAB PLUS CHEMOTHERAPY FOR PRIMARY ADVANCED OR RECURRENT ENDOMETRIAL CANCER FROM TAIWAN’S NATIONAL HEALTH INSURANCE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD114 PHARMACOLOGICAL AND ELECTRONIC CIGARETTE INTERVENTIONS FOR SMOKING CESSATION IN PREGNANCY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD274 ECONOMIC EVALUATION OF USING A UNIT DOSE DISPENSING ROBOT IN A THAI TERTIARY HOSPITAL

    Oct 1, 2025, 00:00

  • RWD65 BALANCING INNOVATION AND AFFORDABILITY: HEALTH SYSTEM TRADE-OFFS IN THAILAND’S REIMBURSEMENT RESTRICTION POLICIES FOR HIGH-COST MEDICINES

    Oct 1, 2025, 00:00

  • RWD301 EXPLORING DIAGNOSTIC PATHWAYS AND FACTORS FOR EARLY DETECTION OF LUNG CANCER IN SMALL AND LARGE NODULE PATIENTS

    Oct 1, 2025, 00:00

  • RWD144 PREVALENCE AND HEALTHCARE RESOURCE UTILIZATION TREND IN LUNG CANCER, COLORECTAL CANCER, BREAST CANCER, AND PROSTATE CANCER IN JAPAN 2016–2024

    Oct 1, 2025, 00:00

  • RWD142 ANALYSIS OF IMPLEMENTATION AND TERMINATION CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS FOR NEW DRUGS UNDER TAIWAN’S NATIONAL HEALTH INSURANCE SYSTEM

    Oct 1, 2025, 00:00

  • RWD5 UNLOCKING THE STRATEGIC POTENTIAL OF REAL-WORLD EVIDENCE IN THE ASIA – PACIFIC PHARMACEUTICAL MARKET: EXECUTIVE INSIGHTS AND COMMERCIAL IMPLICATIONS

    Oct 1, 2025, 00:00

  • RWD118 DESIGNING A PHYSICIAN CAPACITY-BASED PAYMENT FRAMEWORK UNDER A GLOBAL BUDGET: INSIGHTS FROM PHYSICIAN-LEVEL CLAIMS DATA

    Oct 1, 2025, 00:00

  • RWD98 GENOME-WIDE AND PHENOME-WIDE ANALYSES TO IDENTIFY HIGH-RISK PROFILES FOR TYPE 1 DIABETES

    Oct 1, 2025, 00:00

  • RWD171 RESEARCH ON STAKEHOLDER COLLABORATION MECHANISM FOR MEDICAL DATA SHARING: A THREE-PARTY EVOLUTIONARY GAME ANALYSIS

    Oct 1, 2025, 00:00

  • RWD228 ASSOCIATION BETWEEN ANTICHOLINERGIC BURDEN AND THE RISK OF CARDIOVASCULAR EVENTS IN OLDER ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD1 FROM INFECTION TO RECOVERY: HEALTH-RELATED QUALITY OF LIFE TRAJECTORIES AMONG COVID-19 PATIENTS IN SELANGOR

    Oct 1, 2025, 00:00

  • RWD79 SEX DIFFERENCES IN THE NATIONWIDE INCIDENCE OF NEURODEVELOPMENTAL DISORDERS AMONG CHILDREN IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD280 THE LONG-TERM EFFECTS OF OPIOID USE BEFORE TOTAL JOINT REPLACEMENT SURGERY: A DOSE-RESPONSE TRIAL EMULATION USING NEW ZEALAND LINKED ADMINISTRATIVE DATA

    Oct 1, 2025, 00:00

  • RWD159 PREFERENCES AND WILLINGNESS TO PAY FOR MAINTENANCE INHALERS AMONG ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THAILAND: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD245 ARTIFICIAL INTELLIGENCE-POWERED IDENTIFICATION, ACCESS, AND UTILITY MAPPING OF REAL-WORLD DATA SOURCES FOR LUNG CANCER IN ASIA PACIFIC

    Oct 1, 2025, 00:00

  • RWD293 COST-EFFECTIVENESS OF DOSTARLIMAB FOR ADVANCED OR RECURRENT MSI-H/DMMR ENDOMETRIAL CANCER IN ANTI-PD1/PD-L1 NAïVE PATIENTS: A TAIWAN'S NATIONAL HEALTH INSURANCE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD24 ACCEPTANCE OF REAL-WORLD EVIDENCE IN HTA IN JAPAN: IS THE POTENTIAL BEING REALIZED?

    Oct 1, 2025, 00:00

  • RWD205 COST-EFFECTIVENESS OF CONCURRENT KOREAN AND WESTERN MEDICINE TREATMENT VS. USUAL CARE FOR CAR ACCIDENT-RELATED WHIPLASH INJURIES IN KOREA: A MARKOV MODEL DECISION ANALYSIS

    Oct 1, 2025, 00:00

  • RWD67 ASSOCIATIONS BETWEEN SLEEP DURATION AND LIFESTYLE BEHAVIORS AMONG ADOLESCENTS IN HONG KONG: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD265 A REVIEW OF THE RECENT HISTORY OF THE USE OF RWE IN AUSTRALIAN PBAC DECISION MAKING

    Oct 1, 2025, 00:00

  • RWD322 MENTAL HEALTH AS MEDIATOR LINKING AGE-FRIENDLY COMMUNITIES TO CARDIOVASCULAR MULTIMORBIDITY: EVIDENCE FROM A LARGE NATIONAL COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD267 HEALTH INSURANCE STRATEGIES TO IMPROVE HEALTH EQUITY AMONG PATIENTS WITH RARE DISEASES IN CHINA: A MICROSIMULATION-BASED STUDY

    Oct 1, 2025, 00:00

  • RWD77 HEALTHCARE UTILIZATION PATTERNS IN EARLY-STAGE BREAST CANCER TAIWANESE PATIENTS: A REAL WORLD EVIDENCE-BASED SUBTYPE-SPECIFIC STUDY

    Oct 1, 2025, 00:00

  • RWD94 ASSOCIATION BETWEEN USE OF A MULTIDISCIPLINARY NURSE- AND ALLIED HEALTH-LED MANAGEMENT SERVICE FOR COPD AND SUBSEQUENT HOSPITALIZATION DUE TO AMBULATORY CARE SENSITIVE CONDITIONS

    Oct 1, 2025, 00:00

  • RWD258 ONE METHOD OF BREAKING DOWN MEDICAL EXPENSES BY ILLNESS: ESTIMATING MARGINAL AND AVERAGE BURDEN

    Oct 1, 2025, 00:00

  • RWD277 COST-UTILITY IN DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION [DESTINY-HF]: A PRAGMATIC RANDOMIZED CONTROLLED TRIAL-BASED ECONOMIC EVALUATION

    Oct 1, 2025, 00:00

  • RWD32 LEVERAGING REAL WORLD RADIATION MEDICINE HEALTH DATA TO DRIVE EVIDENCE-BASED CANCER CARE POLICIES: AN INSIGHTS FROM THE IAEA SUNRISE PROJECT

    Oct 1, 2025, 00:00

  • RWD148 GLOBAL LANDSCAPE OF NOVEL CLINICAL TRIAL DESIGNS: A CROSS-SECTIONAL ANALYSIS OF WHO REGISTERED TRIALS

    Oct 1, 2025, 00:00

  • RWD207 COMPARISON AND POLICY IMPLICATIONS OF AMBULANCE DURATION AND ASSOCIATED COSTS FOR SUICIDAL PRESENTATIONS VERSUS GENERAL PRESENTATIONS IN AUSTRALIA

    Oct 1, 2025, 00:00

  • RWD224 PREVALENCE AND ADVANCED SYSTEMIC TREATMENT PRESCRIPTION PATTERNS FOR SCALP PSORIASIS IN THE REAL-WORLD DERMATOLOGY SETTING IN THE UNITED STATES

    Oct 1, 2025, 00:00

  • RWD243 EFFECT OF ANGIOTENSIN II RECEPTOR BLOCKERS ON ALZHEIMER'S DISEASE PROGRESSION: A POPULATION-BASED COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD260 A COMPARATIVE ANALYSIS OF THE REDAPT SYSTEM IN REVISION TOTAL HIP ARTHROPLASTY: EVIDENCE FROM A LARGE US CLAIMS DATABASE

    Oct 1, 2025, 00:00

  • RWD96 ESTIMATING HEALTHCARE COSTS ASSOCIATED WITH ISCHEMIC HEART DISEASE AND STROKE USING SEVERAL DIFFERENT STATISTICAL MODELS

    Oct 1, 2025, 00:00

  • RWD237 EVALUATING THE HEALTH IMPACT AND COST-EFFECTIVENESS OF GENDER-NEUTRAL VACCINATION OF 9-VALENT HUMAN PAPILLOMAVIRUS VACCINE IN THE PHILIPPINES USING A DYNAMIC TRANSMISSION MODEL

    Oct 1, 2025, 00:00

  • RWD7 GLOBAL INCIDENCE, RISK FACTORS, AND TRENDS OF PHARYNGEAL CANCER BY ANATOMICAL SITES: A SYSTEMATIC ANALYSIS OF CANCER REGISTRIES

    Oct 1, 2025, 00:00

  • RWD281 LEVERAGING NATIONWIDE HEALTH AND INSURANCE RECORDS TO TRACK BIOLOGIC DRUG DIFFUSION IN IBD: A 20-YEAR REAL-WORLD STUDY FROM ISRAEL

    Oct 1, 2025, 00:00

  • RWD99 ASSESSING THE SOCIOECONOMIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY ON CARER’S LIFE IN AUSTRALIA: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD44 COMPARATIVE EFFICACY AND SAFETY OF SODIUM PICOSULFATE AND POLYETHYLENE GLYCOL IN CHINESE POPULATION: A META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD64 REAL-WORLD ANALYSIS OF HEALTHCARE RESOURCE UTILIZATION IN PATENTS WITH CORONARY ARTERY DISEASE UNDERGOING PACLITAXEL-COATED BALLOON ANGIOPLASTY WITH AND WITHOUT INTRAVASCULAR ULTRASOUND GUIDANCE

    Oct 1, 2025, 00:00

  • RWD62 TREATMENT PATTERNS FOR CHEMOTHERAPY-INDUCED ANEMIA IN CHINESE POPULATION: A MULTI-CENTER RETROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD231 IMPACT OF CHILD MALTREATMENT ON THE COSTS OF HEALTH SERVICE USE AND PRODUCTIVITY LOSS: FINDINGS FROM THE AUSTRALIAN CHILD MALTREATMENT STUDY

    Oct 1, 2025, 00:00

  • RWD95 COST OF ILLNESS ANALYSIS OF SELF-INJECTION OF BIOLOGICS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN JAPAN

    Oct 1, 2025, 00:00

  • RWD296 PRICING, INNOVATION, AND ACCESS-DETERMINANTS OF DRUG REIMBURSEMENT DECISIONS IN TAIWAN’S NHI SYSTEM

    Oct 1, 2025, 00:00

  • RWD146 ASSOCIATION BETWEEN FRAILTY STATUS AND GLYCEMIC CONTROL IN MIDDLE-AGED AND OLDER ADULTS WITH TYPE 2 DIABETES: A CROSS-SECTIONAL ANALYSIS OF THE UK BIOBANK COHORT

    Oct 1, 2025, 00:00

  • RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023

    Oct 1, 2025, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »